[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341547-105":59,"doc-detail-341547-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","oncological-and-reproductive-outcomes-of-endometrial-atypical-hyperplasia-and-endometrial-cancer-patients-undergoing-conservative-therapy-with-hysteroscopic-resection-a-systematic-review-and-meta-analysis","Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection - A systematic review and meta-analysis","","Objective: conduct a systematic review and meta-analysis of studies assessing oncological and reproductive outcomes in patients with endometrial atypical hyperplasia (AH) and endometrioid endometrial cancer (EEC) treated conservatively with hysteroscopic resection (HR). Methods: followed PRISMA, aligned with Cochrane Handbook methods, retrospectively registered in PROSPERO; searched PubMed, Embase, and Cochrane Library through Oct 10, 2023; assessed quality using Newcastle–Ottawa Scale items and MInS for NRS. Primary endpoints were complete response, pregnancy, and live birth after HR-based therapy; secondary endpoint recurrence rate. Results included CR and reproductive outcomes, with subset analyses by BMI and progestin strategy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncological-and-reproductive-outcomes-of-endometrial-atypical-hyperplasia-and-endometrial-cancer-patients-undergoing-conservative-therapy-with-hysteroscopic-resection-a-systematic-review-and-meta-analysis/341547/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncological-and-reproductive-outcomes-of-endometrial-atypical-hyperplasia-and-endometrial-cancer-patients-undergoing-conservative-therapy-with-hysteroscopic-resection-a-systematic-review-and-meta-analysis/341547.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the systematic review and meta-analysis?","Question",{"text":113,"@type":114},"To evaluate oncological and reproductive outcomes in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer undergoing conservative therapy with hysteroscopic resection.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were eligible studies searched and quality assessed?",{"text":118,"@type":114},"The review followed PRISMA and Cochrane methods, used a PROSPERO registration, searched PubMed, Embase, and the Cochrane Library up to October 10, 2023, and assessed study quality using tools based on the Newcastle–Ottawa Scale and the Methodological Index for Nonrandomized Studies.",{"name":120,"@type":111,"acceptedAnswer":121},"Which endpoints were considered primary and which were secondary?",{"text":122,"@type":114},"Primary endpoints were complete response, pregnancy, and live birth rates following HR-based therapy. The recurrence rate served as the secondary endpoint.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341547,1790122146,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1111/aogs.14815  \nSYS T E MAT I C R E VI E W  \nOncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection:  \nA systematic review and meta-analysis  \nShuangshuang Zhao1,2 | Jingying Zhang1,2 | Ye Yan1,2 | Lina Tian1,2 | Lingli Chen1,2 | Xingyu Zheng1,2 | Yiqing Sun1,2 | Wenyan Tian1,2 | Fengxia Xue1,2 | Yingmei Wang1,2   \n1Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China  \n2Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China  \nCorrespondence  \nYingmei Wang, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin 300052, China. [Email:](Email: wangyingmei@tmu.edu.cn)[ wangyingmei@tmu.edu.cn](Email: wangyingmei@tmu.edu.cn)  \nFunding information  \nChina Anti-Cancer AssociationHengrui PARP Nicotinamide Cancer Research Fund, Grant/Award Number:  \nCETSDHRCORP252007; Tianjin Municipal Health Commission, Grant/ Award Number: TJWJ2022XK009 and TJYXZDXK-031A; National Natural Science Foundation of China, Grant/ Award Number: 81972448 and 82172626; Key Technologies Research and Development Program, Grant/Award Number: 2022YFC2704402  \nAbstract  \nIntroduction: Our objective was to conduct a systematic review and meta-analysis of studies evaluating the oncological and reproductive outcomes of patients with endometrial atypical hyperplasia (AH) and endometrioid endometrial cancer (EEC) undergoing conservative therapy with hysteroscopic resection (HR) .  \nMaterial and methods: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for systematic reviews and meta-analyses. The study strictly followed the methodological framework proposed by the Cochrane Handbook and was retrospectively registered in PROSPERO (CRD42023469986) . Searches were conducted in PubMed, Embase, and the Cochrane Library, from inception to October 10, 2023. A checklist based on items of the Newcastle–Ottawa Scale and the Methodological Index for Nonrandomized Studies was used for quality assessment. The primary end points for this meta-analysis were complete response (CR), pregnancy, and live birth rates following HR-based therapy in patients with EEC or AH. The secondary end point was the recurrence rate (RR) .  \nResults: Twenty-one articles involving 407 patients with clinical stage IA, low or intermediate grade, EEC, and 444 patients with AH managed with HR-based conservative treatment were included for this systematic review. CR to HR-based conservative therapy was achieved in 88.6% of patients with EEC and 97.0% of patients with AH. Of these, 30. 6% and 24. 2%, respectively, had live births. The overall pooled disease RR was 18. 3% and 10. 8% in patients with EEC and AH, respectively. Further subset analyses revealed that EEC patients with body mass index (BMI) ≤28 kg/m2 had higher CR rates as well as higher chances of pregnancy and live birth (91 . 6% CR, 32.9%  \n\n| Abbreviations: AH, atypical hyperplasia; BMI, body mass index; CR, complete response; EC, endometrial cancer; EEC, endometrioid endometrial cancer; GnRHa, gonadotropin-releasing hormone agonist; G1, grade 1; G2, grade 2; HR, hysteroscopic resection; PROSPERO, International Prospective Register of Systematic Reviews; LNG-IUS, levonorgestrel intrauterine system; OP, oral progestins; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RR, recurrence rate. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cbr>© 2024 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on beh","cbCaicKbGjDeMEOu","https://ap.wps.com/l/cbCaicKbGjDeMEOu","pdf",4345445,15,"English","# Introduction\n# Material and methods\n# Results\n## Primary outcomes\n## Subset analyses\n# Conclusions","[{\"question\":\"What is the main objective of the systematic review and meta-analysis?\",\"answer\":\"To evaluate oncological and reproductive outcomes in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer undergoing conservative therapy with hysteroscopic resection.\"},{\"question\":\"How were eligible studies searched and quality assessed?\",\"answer\":\"The review followed PRISMA and Cochrane methods, used a PROSPERO registration, searched PubMed, Embase, and the Cochrane Library up to October 10, 2023, and assessed study quality using tools based on the Newcastle–Ottawa Scale and the Methodological Index for Nonrandomized Studies.\"},{\"question\":\"Which endpoints were considered primary and which were secondary?\",\"answer\":\"Primary endpoints were complete response, pregnancy, and live birth rates following HR-based therapy. The recurrence rate served as the secondary endpoint.\"}]","Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection - A systematic review and meta-analysis | PDF",1790042483,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cd74a853eeb80bb7bb5a96528266386.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/454276a9a468fdda13cc1eda75e47367.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60891e23c3ec5b0a1a4c581382a49c60.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a65a05c2e9234f4d6b66d95d09f6e9b.webp",980,1287]